HEADER VIRAL PROTEIN/IMMUNE SYSTEM 30-JUL-22 8DW3 TITLE CRYO-EM STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH ANTI-SARS-COV-2 TITLE 2 DARPIN,SR16M, AND TWO ANTIBODY FABS, S309 AND CR3022 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTI-SARS-COV-2 DARPIN SR16M; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: SPIKE PROTEIN S1; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: RECEPTOR BINDING DOMAIN (UNP RESIDUES 330-526); COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: ANTIBODY S309 LIGHT CHAIN; COMPND 12 CHAIN: C; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 4; COMPND 15 MOLECULE: ANTIBODY S309 HEAVY CHAIN; COMPND 16 CHAIN: D; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 5; COMPND 19 MOLECULE: ANTIBODY CR3022 HEAVY CHAIN; COMPND 20 CHAIN: H; COMPND 21 ENGINEERED: YES; COMPND 22 MOL_ID: 6; COMPND 23 MOLECULE: ANTIBODY CR3022 LIGHT CHAIN; COMPND 24 CHAIN: L; COMPND 25 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: 293 FREESTYLE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVRC8400; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 13 2; SOURCE 14 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 15 ORGANISM_TAXID: 2697049; SOURCE 16 GENE: S, 2; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: 293 FREESTYLE; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PVRC8400; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 28 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 30 EXPRESSION_SYSTEM_CELL_LINE: 293 FREESTYLE; SOURCE 31 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 32 EXPRESSION_SYSTEM_PLASMID: PVRC8400; SOURCE 33 MOL_ID: 4; SOURCE 34 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 35 ORGANISM_COMMON: HUMAN; SOURCE 36 ORGANISM_TAXID: 9606; SOURCE 37 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 38 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 39 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 40 EXPRESSION_SYSTEM_CELL_LINE: 293 FREESTYLE; SOURCE 41 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 42 EXPRESSION_SYSTEM_PLASMID: PVRC8400; SOURCE 43 MOL_ID: 5; SOURCE 44 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 45 ORGANISM_COMMON: HUMAN; SOURCE 46 ORGANISM_TAXID: 9606; SOURCE 47 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 48 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 49 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 50 EXPRESSION_SYSTEM_CELL_LINE: 293 FREESTYLE; SOURCE 51 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 52 EXPRESSION_SYSTEM_PLASMID: PVRC8400; SOURCE 53 MOL_ID: 6; SOURCE 54 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 55 ORGANISM_COMMON: HUMAN; SOURCE 56 ORGANISM_TAXID: 9606; SOURCE 57 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 58 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 59 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 60 EXPRESSION_SYSTEM_CELL_LINE: 293 FREESTYLE; SOURCE 61 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 62 EXPRESSION_SYSTEM_PLASMID: PVRC8400 KEYWDS DARPINS, ANTI-SARS-COV-2, THERAPEUTICS, COVID-19, VIRAL PROTEIN- KEYWDS 2 IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR Y.D.KWON,J.GORMAN,P.D.KWONG REVDAT 3 23-OCT-24 8DW3 1 REMARK REVDAT 2 15-MAR-23 8DW3 1 JRNL REVDAT 1 07-DEC-22 8DW3 0 JRNL AUTH V.CHONIRA,Y.D.KWON,J.GORMAN,J.B.CASE,Z.KU,R.SIMEON, JRNL AUTH 2 R.G.CASNER,D.R.HARRIS,A.S.OLIA,T.STEPHENS,L.SHAPIRO, JRNL AUTH 3 M.F.BENDER,H.BOYD,I.T.TENG,Y.TSYBOVSKY,F.KRAMMER,N.ZHANG, JRNL AUTH 4 M.S.DIAMOND,P.D.KWONG,Z.AN,Z.CHEN JRNL TITL A POTENT AND BROAD NEUTRALIZATION OF SARS-COV-2 VARIANTS OF JRNL TITL 2 CONCERN BY DARPINS. JRNL REF NAT.CHEM.BIOL. V. 19 284 2023 JRNL REFN ESSN 1552-4469 JRNL PMID 36411391 JRNL DOI 10.1038/S41589-022-01193-2 REMARK 2 REMARK 2 RESOLUTION. 4.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, UCSF CHIMERA, PHENIX, REMARK 3 CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 7BNO REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : CC REMARK 3 OVERALL ANISOTROPIC B VALUE : 134.000 REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.260 REMARK 3 NUMBER OF PARTICLES : 37197 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8DW3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267466. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : DARPIN SR16M IN COMPLEX WITH REMARK 245 SARS-COV-2 RBD AND ANTIBODY REMARK 245 FABS, S309 AND CR3022 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : DARPIN SR16M IN COMPLEX WITH REMARK 245 SARS-COV-2 RBD AND ANTIBODY FABS, S309 AND CR3022 REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1250.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4020.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, H, L, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 170 REMARK 465 LEU A 171 REMARK 465 ALA A 172 REMARK 465 ALA A 173 REMARK 465 ALA A 174 REMARK 465 LEU A 175 REMARK 465 PRO B 330 REMARK 465 ASN B 331 REMARK 465 ILE B 332 REMARK 465 THR B 333 REMARK 465 ASN B 334 REMARK 465 CYS C 214 REMARK 465 SER D 229 REMARK 465 CYS D 230 REMARK 465 LYS H 133 REMARK 465 SER H 134 REMARK 465 THR H 135 REMARK 465 SER H 136 REMARK 465 CYS H 220 REMARK 465 CYS L 220 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG C 62 CG GLU C 80 1.89 REMARK 500 OG1 THR B 345 OG SER D 109 2.11 REMARK 500 O ILE C 106 OH TYR C 140 2.18 REMARK 500 O SER C 121 NE2 GLN C 124 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO C 204 CG PRO C 204 CD -0.442 REMARK 500 PRO C 204 CD PRO C 204 N 0.095 REMARK 500 PRO D 28 CB PRO D 28 CG 0.349 REMARK 500 PRO D 28 CG PRO D 28 CD -0.997 REMARK 500 PRO D 28 CD PRO D 28 N 0.115 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 432 CA - CB - SG ANGL. DEV. = 7.2 DEGREES REMARK 500 LEU C 11 CA - CB - CG ANGL. DEV. = 16.0 DEGREES REMARK 500 PRO C 81 CA - N - CD ANGL. DEV. = -15.6 DEGREES REMARK 500 PRO C 204 CA - N - CD ANGL. DEV. = -17.4 DEGREES REMARK 500 PRO C 204 CA - CB - CG ANGL. DEV. = -18.3 DEGREES REMARK 500 PRO C 204 N - CD - CG ANGL. DEV. = -21.7 DEGREES REMARK 500 PRO D 28 CA - N - CD ANGL. DEV. = -14.5 DEGREES REMARK 500 PRO D 28 N - CA - CB ANGL. DEV. = -8.5 DEGREES REMARK 500 PRO D 28 CA - CB - CG ANGL. DEV. = -23.0 DEGREES REMARK 500 PRO D 28 N - CD - CG ANGL. DEV. = -37.8 DEGREES REMARK 500 PRO L 126 CA - N - CD ANGL. DEV. = -10.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO B 337 77.20 -66.72 REMARK 500 TYR B 396 130.09 -35.82 REMARK 500 ASP B 428 49.90 39.57 REMARK 500 CYS B 432 128.67 -170.24 REMARK 500 ASP B 442 53.33 -93.05 REMARK 500 ASN B 481 -63.09 -95.53 REMARK 500 SER C 7 134.25 62.08 REMARK 500 PRO C 45 -179.98 -69.63 REMARK 500 ALA C 52 -3.67 68.69 REMARK 500 SER C 77 -71.89 64.41 REMARK 500 HIS C 92 15.94 -141.19 REMARK 500 SER C 95 -143.09 53.11 REMARK 500 SER D 52 -168.25 -78.47 REMARK 500 GLN D 62 1.40 -68.72 REMARK 500 PRO D 161 -169.16 -62.73 REMARK 500 ASN D 218 48.92 33.53 REMARK 500 ASN H 77 62.24 60.69 REMARK 500 ASP H 148 61.86 60.12 REMARK 500 ASN H 208 51.24 39.59 REMARK 500 ASN L 35 54.88 -93.14 REMARK 500 ALA L 57 -4.79 67.70 REMARK 500 PRO L 147 -177.69 -58.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 342 ASN B 343 -145.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-27750 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-27749 RELATED DB: EMDB DBREF 8DW3 A 15 175 PDB 8DW3 8DW3 15 175 DBREF 8DW3 B 330 526 UNP P0DTC2 SPIKE_SARS2 330 526 DBREF 8DW3 C 1 214 PDB 8DW3 8DW3 1 214 DBREF 8DW3 D 1 230 PDB 8DW3 8DW3 1 230 DBREF 8DW3 H 0 220 PDB 8DW3 8DW3 0 220 DBREF 8DW3 L 1 220 PDB 8DW3 8DW3 1 220 SEQRES 1 A 161 GLY LYS LYS LEU LEU GLU ALA ALA ARG ALA GLY GLN ASP SEQRES 2 A 161 ASP GLU VAL ARG ILE LEU MET ALA ASN GLY ALA ASP VAL SEQRES 3 A 161 ASN ALA LEU ASP LEU PHE GLY VAL THR PRO LEU HIS LEU SEQRES 4 A 161 ALA ALA GLU ARG GLY HIS LEU GLU ILE VAL GLU VAL LEU SEQRES 5 A 161 LEU LYS ASN GLY ALA ASP VAL ASN ALA GLY ASP ALA PHE SEQRES 6 A 161 GLY ARG THR PRO LEU HIS LEU ALA ALA LEU GLY GLY HIS SEQRES 7 A 161 LEU GLU ILE VAL GLU VAL LEU LEU LYS ASN GLY ALA ASP SEQRES 8 A 161 VAL ASN ALA CYS ASP LEU TYR GLY VAL THR PRO LEU HIS SEQRES 9 A 161 LEU ALA ALA GLY LEU GLY HIS LEU GLU ILE VAL GLU VAL SEQRES 10 A 161 LEU LEU LYS ASN GLY ALA ASP VAL ASN ALA GLN ASP LYS SEQRES 11 A 161 PHE GLY LYS THR ALA PHE ASP ILE SER ILE ASP ASN GLY SEQRES 12 A 161 ASN GLU ASP LEU ALA GLU ILE LEU GLN SER SER SER LYS SEQRES 13 A 161 LEU ALA ALA ALA LEU SEQRES 1 B 197 PRO ASN ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE SEQRES 2 B 197 ASN ALA THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG SEQRES 3 B 197 LYS ARG ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU SEQRES 4 B 197 TYR ASN SER ALA SER PHE SER THR PHE LYS CYS TYR GLY SEQRES 5 B 197 VAL SER PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN SEQRES 6 B 197 VAL TYR ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL SEQRES 7 B 197 ARG GLN ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP SEQRES 8 B 197 TYR ASN TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL SEQRES 9 B 197 ILE ALA TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY SEQRES 10 B 197 GLY ASN TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER SEQRES 11 B 197 ASN LEU LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE SEQRES 12 B 197 TYR GLN ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY SEQRES 13 B 197 PHE ASN CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN SEQRES 14 B 197 PRO THR ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL SEQRES 15 B 197 VAL LEU SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL SEQRES 16 B 197 CYS GLY SEQRES 1 C 214 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 C 214 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 C 214 GLN THR VAL SER SER THR SER LEU ALA TRP TYR GLN GLN SEQRES 4 C 214 LYS PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SEQRES 5 C 214 SER SER ARG ALA THR GLY ILE PRO ASP ARG PHE SER GLY SEQRES 6 C 214 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 C 214 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 C 214 HIS ASP THR SER LEU THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 C 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 C 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 C 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 C 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 C 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 C 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 C 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 C 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 C 214 PHE ASN ARG GLY GLU CYS SEQRES 1 D 230 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 D 230 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 D 230 TYR PRO PHE THR SER TYR GLY ILE SER TRP VAL ARG GLN SEQRES 4 D 230 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY TRP ILE SER SEQRES 5 D 230 THR TYR ASN GLY ASN THR ASN TYR ALA GLN LYS PHE GLN SEQRES 6 D 230 GLY ARG VAL THR MET THR THR ASP THR SER THR THR THR SEQRES 7 D 230 GLY TYR MET GLU LEU ARG ARG LEU ARG SER ASP ASP THR SEQRES 8 D 230 ALA VAL TYR TYR CYS ALA ARG ASP TYR THR ARG GLY ALA SEQRES 9 D 230 TRP PHE GLY GLU SER LEU ILE GLY GLY PHE ASP ASN TRP SEQRES 10 D 230 GLY GLN GLY THR LEU VAL THR VAL SER SER ALA SER THR SEQRES 11 D 230 LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SEQRES 12 D 230 SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL SEQRES 13 D 230 LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SEQRES 14 D 230 SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA SEQRES 15 D 230 VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER VAL SEQRES 16 D 230 VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR TYR SEQRES 17 D 230 ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL SEQRES 18 D 230 ASP LYS LYS VAL GLU PRO LYS SER CYS SEQRES 1 H 221 THR GLN MET GLN LEU VAL GLN SER GLY THR GLU VAL LYS SEQRES 2 H 221 LYS PRO GLY GLU SER LEU LYS ILE SER CYS LYS GLY SER SEQRES 3 H 221 GLY TYR GLY PHE ILE THR TYR TRP ILE GLY TRP VAL ARG SEQRES 4 H 221 GLN MET PRO GLY LYS GLY LEU GLU TRP MET GLY ILE ILE SEQRES 5 H 221 TYR PRO GLY ASP SER GLU THR ARG TYR SER PRO SER PHE SEQRES 6 H 221 GLN GLY GLN VAL THR ILE SER ALA ASP LYS SER ILE ASN SEQRES 7 H 221 THR ALA TYR LEU GLN TRP SER SER LEU LYS ALA SER ASP SEQRES 8 H 221 THR ALA ILE TYR TYR CYS ALA GLY GLY SER GLY ILE SER SEQRES 9 H 221 THR PRO MET ASP VAL TRP GLY GLN GLY THR THR VAL THR SEQRES 10 H 221 VAL ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 H 221 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 12 H 221 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 221 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 H 221 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 H 221 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 H 221 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 H 221 ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS SEQRES 1 L 220 ASP ILE GLN LEU THR GLN SER PRO ASP SER LEU ALA VAL SEQRES 2 L 220 SER LEU GLY GLU ARG ALA THR ILE ASN CYS LYS SER SER SEQRES 3 L 220 GLN SER VAL LEU TYR SER SER ILE ASN LYS ASN TYR LEU SEQRES 4 L 220 ALA TRP TYR GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU SEQRES 5 L 220 LEU ILE TYR TRP ALA SER THR ARG GLU SER GLY VAL PRO SEQRES 6 L 220 ASP ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR SEQRES 7 L 220 LEU THR ILE SER SER LEU GLN ALA GLU ASP VAL ALA VAL SEQRES 8 L 220 TYR TYR CYS GLN GLN TYR TYR SER THR PRO TYR THR PHE SEQRES 9 L 220 GLY GLN GLY THR LYS VAL GLU ILE LYS ARG THR VAL ALA SEQRES 10 L 220 ALA PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN SEQRES 11 L 220 LEU LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN SEQRES 12 L 220 ASN PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL SEQRES 13 L 220 ASP ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL SEQRES 14 L 220 THR GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SEQRES 15 L 220 SER THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS SEQRES 16 L 220 LYS VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SEQRES 17 L 220 SER PRO VAL THR LYS SER PHE ASN ARG GLY GLU CYS HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 7 NAG 2(C8 H15 N O6) FORMUL 7 BMA C6 H12 O6 HELIX 1 AA1 LYS A 16 GLY A 25 1 10 HELIX 2 AA2 GLN A 26 ALA A 35 1 10 HELIX 3 AA3 THR A 49 GLY A 58 1 10 HELIX 4 AA4 HIS A 59 ASN A 69 1 11 HELIX 5 AA5 THR A 82 GLY A 91 1 10 HELIX 6 AA6 LEU A 93 GLY A 103 1 11 HELIX 7 AA7 THR A 115 LEU A 123 1 9 HELIX 8 AA8 HIS A 125 ASN A 135 1 11 HELIX 9 AA9 THR A 148 ASN A 156 1 9 HELIX 10 AB1 ASN A 158 SER A 169 1 12 HELIX 11 AB2 PHE B 338 ASN B 343 1 6 HELIX 12 AB3 SER B 349 TRP B 353 5 5 HELIX 13 AB4 ASP B 364 TYR B 369 5 6 HELIX 14 AB5 GLY B 404 ARG B 408 5 5 HELIX 15 AB6 LYS B 417 ASN B 422 1 6 HELIX 16 AB7 GLY B 502 GLN B 506 5 5 HELIX 17 AB8 SER C 121 LYS C 126 1 6 HELIX 18 AB9 PRO D 28 TYR D 32 5 5 HELIX 19 AC1 SER D 170 ALA D 172 5 3 HELIX 20 AC2 PRO D 199 LEU D 203 5 5 HELIX 21 AC3 GLY H 28 TYR H 32 5 5 HELIX 22 AC4 PRO H 62 GLN H 65 5 4 HELIX 23 AC5 SER H 191 LEU H 193 5 3 HELIX 24 AC6 GLN L 85 VAL L 89 5 5 HELIX 25 AC7 SER L 127 GLY L 134 1 8 HELIX 26 AC8 LYS L 189 HIS L 195 1 7 SHEET 1 AA1 4 ASN B 354 LYS B 356 0 SHEET 2 AA1 4 ALA B 397 ILE B 402 -1 O ALA B 397 N LYS B 356 SHEET 3 AA1 4 TYR B 508 SER B 514 -1 O TYR B 508 N ILE B 402 SHEET 4 AA1 4 GLY B 431 ASN B 437 -1 N TRP B 436 O ARG B 509 SHEET 1 AA2 2 LEU B 452 ARG B 454 0 SHEET 2 AA2 2 LEU B 492 SER B 494 -1 O GLN B 493 N TYR B 453 SHEET 1 AA3 2 TYR B 473 GLN B 474 0 SHEET 2 AA3 2 CYS B 488 TYR B 489 -1 O TYR B 489 N TYR B 473 SHEET 1 AA4 4 LEU C 4 THR C 5 0 SHEET 2 AA4 4 THR C 20 ALA C 25 -1 O ARG C 24 N THR C 5 SHEET 3 AA4 4 ASP C 71 THR C 75 -1 O PHE C 72 N CYS C 23 SHEET 4 AA4 4 SER C 64 SER C 68 -1 N SER C 66 O THR C 73 SHEET 1 AA5 3 LEU C 34 GLN C 39 0 SHEET 2 AA5 3 VAL C 86 GLN C 91 -1 O VAL C 86 N GLN C 39 SHEET 3 AA5 3 THR C 97 PHE C 98 -1 O THR C 97 N GLN C 91 SHEET 1 AA6 3 LEU C 34 GLN C 39 0 SHEET 2 AA6 3 VAL C 86 GLN C 91 -1 O VAL C 86 N GLN C 39 SHEET 3 AA6 3 THR C 102 LYS C 103 -1 O THR C 102 N TYR C 87 SHEET 1 AA7 2 ILE C 49 TYR C 50 0 SHEET 2 AA7 2 SER C 54 ARG C 55 -1 O SER C 54 N TYR C 50 SHEET 1 AA8 4 SER C 114 PHE C 118 0 SHEET 2 AA8 4 THR C 129 ASN C 137 -1 O VAL C 133 N PHE C 118 SHEET 3 AA8 4 SER C 174 SER C 182 -1 O SER C 177 N CYS C 134 SHEET 4 AA8 4 SER C 159 VAL C 163 -1 N SER C 162 O SER C 176 SHEET 1 AA9 3 LYS C 145 VAL C 150 0 SHEET 2 AA9 3 VAL C 191 THR C 197 -1 O GLU C 195 N GLN C 147 SHEET 3 AA9 3 THR C 206 ASN C 210 -1 O LYS C 207 N CYS C 194 SHEET 1 AB1 4 GLN D 3 GLN D 6 0 SHEET 2 AB1 4 VAL D 18 SER D 25 -1 O LYS D 23 N VAL D 5 SHEET 3 AB1 4 THR D 78 LEU D 83 -1 O MET D 81 N VAL D 20 SHEET 4 AB1 4 VAL D 68 ASP D 73 -1 N ASP D 73 O THR D 78 SHEET 1 AB2 6 GLU D 10 LYS D 12 0 SHEET 2 AB2 6 THR D 121 VAL D 125 1 O THR D 124 N GLU D 10 SHEET 3 AB2 6 ALA D 92 ASP D 99 -1 N ALA D 92 O VAL D 123 SHEET 4 AB2 6 GLY D 33 GLN D 39 -1 N GLN D 39 O VAL D 93 SHEET 5 AB2 6 LEU D 45 ILE D 51 -1 O GLU D 46 N ARG D 38 SHEET 6 AB2 6 THR D 58 ASN D 59 -1 O ASN D 59 N TRP D 50 SHEET 1 AB3 4 SER D 134 LEU D 138 0 SHEET 2 AB3 4 ALA D 150 LYS D 157 -1 O LEU D 155 N PHE D 136 SHEET 3 AB3 4 TYR D 190 VAL D 198 -1 O VAL D 198 N ALA D 150 SHEET 4 AB3 4 VAL D 177 THR D 179 -1 N HIS D 178 O VAL D 195 SHEET 1 AB4 4 SER D 134 LEU D 138 0 SHEET 2 AB4 4 ALA D 150 LYS D 157 -1 O LEU D 155 N PHE D 136 SHEET 3 AB4 4 TYR D 190 VAL D 198 -1 O VAL D 198 N ALA D 150 SHEET 4 AB4 4 VAL D 183 LEU D 184 -1 N VAL D 183 O SER D 191 SHEET 1 AB5 3 THR D 165 TRP D 168 0 SHEET 2 AB5 3 TYR D 208 HIS D 214 -1 O ASN D 213 N THR D 165 SHEET 3 AB5 3 THR D 219 VAL D 225 -1 O LYS D 223 N CYS D 210 SHEET 1 AB6 4 MET H 2 VAL H 5 0 SHEET 2 AB6 4 LEU H 18 GLY H 26 -1 O LYS H 23 N VAL H 5 SHEET 3 AB6 4 THR H 78 TRP H 83 -1 O ALA H 79 N CYS H 22 SHEET 4 AB6 4 VAL H 68 ASP H 73 -1 N THR H 69 O GLN H 82 SHEET 1 AB7 6 GLU H 10 VAL H 11 0 SHEET 2 AB7 6 THR H 113 THR H 116 1 O THR H 116 N GLU H 10 SHEET 3 AB7 6 ILE H 93 GLY H 99 -1 N TYR H 94 O THR H 113 SHEET 4 AB7 6 TRP H 33 GLN H 39 -1 N GLY H 35 O ALA H 97 SHEET 5 AB7 6 LEU H 45 ILE H 51 -1 O ILE H 51 N ILE H 34 SHEET 6 AB7 6 THR H 58 TYR H 60 -1 O ARG H 59 N ILE H 50 SHEET 1 AB8 4 GLU H 10 VAL H 11 0 SHEET 2 AB8 4 THR H 113 THR H 116 1 O THR H 116 N GLU H 10 SHEET 3 AB8 4 ILE H 93 GLY H 99 -1 N TYR H 94 O THR H 113 SHEET 4 AB8 4 VAL H 108 TRP H 109 -1 O VAL H 108 N GLY H 98 SHEET 1 AB9 4 SER H 124 LEU H 128 0 SHEET 2 AB9 4 THR H 139 TYR H 149 -1 O LEU H 145 N PHE H 126 SHEET 3 AB9 4 TYR H 180 PRO H 189 -1 O VAL H 188 N ALA H 140 SHEET 4 AB9 4 VAL H 167 HIS H 168 -1 N HIS H 168 O VAL H 185 SHEET 1 AC1 3 THR H 155 TRP H 158 0 SHEET 2 AC1 3 TYR H 198 HIS H 204 -1 O ASN H 201 N SER H 157 SHEET 3 AC1 3 THR H 209 VAL H 215 -1 O LYS H 213 N CYS H 200 SHEET 1 AC2 4 THR L 5 SER L 7 0 SHEET 2 AC2 4 ALA L 19 LYS L 24 -1 O LYS L 24 N THR L 5 SHEET 3 AC2 4 ASP L 76 ILE L 81 -1 O LEU L 79 N ILE L 21 SHEET 4 AC2 4 PHE L 68 SER L 73 -1 N SER L 69 O THR L 80 SHEET 1 AC3 5 SER L 10 VAL L 13 0 SHEET 2 AC3 5 THR L 108 ILE L 112 1 O GLU L 111 N VAL L 13 SHEET 3 AC3 5 VAL L 91 GLN L 96 -1 N TYR L 92 O THR L 108 SHEET 4 AC3 5 LEU L 39 GLN L 44 -1 N TYR L 42 O TYR L 93 SHEET 5 AC3 5 LYS L 51 ILE L 54 -1 O LYS L 51 N GLN L 43 SHEET 1 AC4 4 SER L 120 PHE L 124 0 SHEET 2 AC4 4 THR L 135 PHE L 145 -1 O ASN L 143 N SER L 120 SHEET 3 AC4 4 TYR L 179 SER L 188 -1 O SER L 183 N CYS L 140 SHEET 4 AC4 4 SER L 165 VAL L 169 -1 N GLN L 166 O THR L 184 SHEET 1 AC5 3 LYS L 151 VAL L 156 0 SHEET 2 AC5 3 VAL L 197 THR L 203 -1 O GLU L 201 N GLN L 153 SHEET 3 AC5 3 VAL L 211 ASN L 216 -1 O PHE L 215 N TYR L 198 SSBOND 1 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 2 CYS B 379 CYS B 432 1555 1555 2.03 SSBOND 3 CYS B 391 CYS B 525 1555 1555 2.03 SSBOND 4 CYS B 480 CYS B 488 1555 1555 2.03 SSBOND 5 CYS C 23 CYS C 89 1555 1555 2.40 SSBOND 6 CYS C 134 CYS C 194 1555 1555 2.03 SSBOND 7 CYS D 22 CYS D 96 1555 1555 2.03 SSBOND 8 CYS D 154 CYS D 210 1555 1555 2.03 SSBOND 9 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 10 CYS H 144 CYS H 200 1555 1555 2.03 SSBOND 11 CYS L 23 CYS L 94 1555 1555 2.04 SSBOND 12 CYS L 140 CYS L 200 1555 1555 2.03 LINK ND2 ASN B 343 C1 NAG E 1 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.44 CISPEP 1 SER C 7 PRO C 8 0 -5.87 CISPEP 2 TYR C 140 PRO C 141 0 -0.23 CISPEP 3 PHE D 160 PRO D 161 0 -18.82 CISPEP 4 GLU D 162 PRO D 163 0 -7.47 CISPEP 5 PHE H 150 PRO H 151 0 -2.96 CISPEP 6 GLU H 152 PRO H 153 0 0.10 CISPEP 7 SER L 7 PRO L 8 0 -5.36 CISPEP 8 THR L 100 PRO L 101 0 1.78 CISPEP 9 TYR L 146 PRO L 147 0 -8.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000